Developer docs
API playgroundTry for free, no card

Search company profiles

Catalyst OrthoScience

Full company profile

uuid0000oyf

Namestring
Catalyst OrthoScience
Legal namestring
Catalyst OrthoScience Inc.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Catalyst OrthoScience is a private medical device company founded in 2014 and headquartered in Naples, Florida that develops and commercializes shoulder arthroplasty implant systems. The company positions itself as a pure-play shoulder specialist offering a four-system portfolio covering the full shoulder replacement procedure spectrum: the stem-free Catalyst CSR Total Shoulder System (anatomic), the Catalyst Reverse Shoulder System (R1), the Catalyst Fracture Shoulder System (proximal humeral fractures), and the Catalyst Stemmed Anatomic Shoulder System. Its core technical differentiators include canal-sparing (stem-free and short-stem) implant designs, a proprietary non-spherical ellipsoid humeral head intended to replicate native anatomy, a patented multiplanar osteotomy technique, and a Plunge Reamer with automatic depth stop. The company also markets the Archer 3D Targeting Software for preoperative planning and the FDA-cleared Archer Patient-Specific Instrumentation (PSI) developed with Belgian partner 3D-Side, and claims to be the first and only company offering a single-tray portfolio spanning anatomic, reverse, and fracture procedures.

The company generates revenue through hardware sales of its implant systems and associated instruments to hospitals and ambulatory surgery centers (ASCs), supplemented by medical education services delivered through its seven-location Surgeon-to-Surgeon S.I.T.E. training program, webinars, and recorded surgical procedures. Distribution is exclusively domestic (United States) through direct field sales targeting orthopedic surgeons specializing in shoulder procedures, with contract-negotiated (non-public) implant pricing. Primary customers are orthopedic surgeons and the healthcare facilities where they practice, with secondary end-beneficiaries being patients suffering from shoulder arthritis, trauma, or fracture conditions. Catalyst reports cumulative clinical experience exceeding 10,000 shoulder arthroplasty procedures as of September 2024, with published 5-8 year outcome data on 206 shoulders, and holds over 50 issued or pending patents including US Patent D1,048,403 for tuberosity retention rails.

The business is venture-backed, having raised approximately $70 million+ across multiple rounds from 2016 through 2025, with lead investors including RC Capital, Mutual Capital Partners, and River Cities Capital. The company maintains 11-50 employees, is led by CEO Carl O'Connell, and has professionalized its leadership since 2024 with new CCO, CMO, and senior board appointments (including industry veterans from Johnson & Johnson, Tornier, Stryker, and Wright Medical). Recent strategic activity includes FDA 510(k) clearances for the Archer PSI system (February 2026) and expanded Fracture Shoulder System indications (December 2025), positioning Catalyst for portfolio expansion within the shoulder arthroplasty specialty.

Short descriptiontext

Catalyst OrthoScience is a private US medical device company founded in 2014 that develops and commercializes canal-sparing shoulder arthroplasty implant systems, including anatomic, reverse, fracture, and stemmed platforms, serving orthopedic surgeons and hospitals/ASCs through a direct domestic sales model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNaples, United States
HQ citystring
Naples
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
shoulder arthroplasty systems, orthopedic shoulder implants, canal-sparing technology, reverse shoulder replacement, preoperative surgical planning
Industry3 codes
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Shoulder Arthroplasty Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales - Shoulder Implant Systems
TypeHardware Sales
Description

Catalyst OrthoScience generates revenue through the sale of its proprietary shoulder arthroplasty implant systems, including the CSR Total Shoulder System, Reverse Shoulder System, Fracture Shoulder System, and Stemmed Anatomic Shoulder System. Products are sold to hospitals, ambulatory surgery centers (ASCs), and directly to orthopedic surgeons. The company also sells associated instruments, instrumentation sets, and accessory products such as the Tuberosity Repair Kit.

catalystortho.com
2Medical Education Services
TypeProfessional Services
Description

The company provides medical education programs including the Surgeon-to-Surgeon S.I.T.E. program, virtual learning sessions, webinars, recorded surgical procedures, and journal reviews. These programs serve both as revenue-generating services and as GTM tools to drive product adoption.

catalystortho.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Catalyst CSR Total Shoulder System
Description

Anatomic shoulder system with elliptical humeral head design for more natural shoulder replacement.

catalystortho.com
+4 more records
Core offering1 text field

Catalyst OrthoScience designs, develops, and commercializes proprietary shoulder arthroplasty implant systems — including the stem-free CSR Total Shoulder System, Reverse Shoulder System, Fracture Shoulder System, and Stemmed Anatomic — for hospitals, ambulatory surgery centers, and orthopedic surgeons performing anatomic, reverse, and fracture shoulder replacement procedures. The portfolio is complemented by the Archer 3D Targeting Software for preoperative planning and the FDA-cleared Archer Patient-Specific Instrumentation (PSI) for surgical execution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Preserves up to 50% more healthy bone compared to other stemless designs through patented multiplanar osteotomy
+6 more records
Product overview1 text field

Catalyst OrthoScience is a medical technology company specializing in shoulder arthroplasty, offering a portfolio of implant systems designed around four core principles: precision placement, anatomic design, bone preservation, and tissue sparing. The product portfolio centers on five main systems: (1) the Catalyst CSR Total Shoulder System - a stem-free anatomic system featuring an elliptical humeral head and multiplanar osteotomy; (2) the Catalyst Reverse Shoulder System - a single-tray reverse arthroplasty system with bone-sparing inlay stem design; (3) the Catalyst Fracture Shoulder System - specifically designed for proximal humeral fractures with tuberosity management features; (4) the Catalyst Stemmed Anatomic Shoulder System - the company's first stemmed system with convertible capability; and (5) the Archer digital health ecosystem - comprising 3D Targeting Software for preoperative planning and Patient-Specific Instrumentation (PSI) for precise intraoperative execution. The company positions itself as a 'pure play shoulder company' focused exclusively on advancing shoulder arthroplasty through surgeon-focused innovation and procedural efficiency, claiming to be the first and only company offering a single-tray portfolio for anatomic, reverse, and fracture procedures.

Product and service6 records
1Catalyst CSR Total Shoulder System
CategoryShoulder arthroplasty implant system
Description

A stem-free anatomic total shoulder arthroplasty system featuring an elliptical (non-spherical) humeral head designed to replicate native anatomy, with patented multiplanar osteotomy for bone preservation, the Plunge Reamer for automatic depth-controlled preparation, and tissue-sparing instrumentation enabling a subscapularis-sparing surgical approach; targeted at orthopedic surgeons performing anatomic shoulder replacement in hospitals and ambulatory surgery centers.

2Catalyst Reverse Shoulder System (R1)
CategoryShoulder arthroplasty implant system
Description

A reverse shoulder arthroplasty system with a 139-degree metaphyseal-fitting bone-sparing inlay humeral stem, glenosphere options of 32, 36, and 40mm with up to 10mm lateralization, poly inserts with 0–16mm offset, and single-tray instrumentation that reduces surgical steps by up to 46% compared with competitive reverse systems; intended for orthopedic surgeons performing reverse shoulder replacement in hospitals and ASCs.

3Catalyst Fracture Shoulder System
CategoryShoulder arthroplasty implant system
Description

A fracture-specific reverse shoulder arthroplasty system for proximal humeral fractures featuring a tuberosity-specific fossa, patented Tuberosity Retention Rails (US Patent D1,048,403), 135-degree anatomic neck-shaft angle, and press-fit diaphyseal fixation, with FDA 510(k) clearance for expanded anatomic indications; intended for orthopedic surgeons managing proximal humeral fractures in hospitals and ASCs.

4Catalyst Stemmed Anatomic Shoulder System
CategoryShoulder arthroplasty implant system
Description

The first stemmed total shoulder arthroplasty system with an elliptical humeral head, allowing conversion between anatomic hemi-arthroplasty and reverse humerus without stem removal, and compatible with the 3-peg glenoid and Catalyst humeral stems in 36mm and 41mm diameters with short and long options; targeted at orthopedic surgeons needing a convertible stemmed option.

5Archer 3D Targeting Software
CategoryPreoperative surgical planning software
Description

Preoperative shoulder planning software encompassing both anatomic and reverse planning capabilities; creates interactive 3D renderings from patient imaging and delivers personalized surgical plans with individualized implant sizing and placement determination for orthopedic surgeons planning shoulder arthroplasty.

6Archer Patient-Specific Instrumentation (PSI)
CategoryPatient-specific surgical instrumentation
Description

FDA 510(k)-cleared patient-specific instrumentation providing a full suite of humeral and glenoid guides tailored to individual patient anatomy, developed in partnership with Belgian medtech company 3D-Side, enabling orthopedic surgeons to translate 3D preoperative plans into the OR with greater precision and reduced procedural steps; intended for shoulder arthroplasty cases where preoperative Catalyst Archer plans are used.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-25
Description

Belgian medtech company 3D-Side partnered with Catalyst to develop the Archer Patient-Specific Instrumentation (PSI) system. The PSI enables orthopedic surgeons to execute 3D preoperative plans with greater precision and reduced procedural steps. FDA 510(k) clearance received February 2026.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global orthopedic giant with a comprehensive shoulder arthroplasty portfolio (anchored by the Wright Medical shoulder franchise). Directly competes with Catalyst across anatomic, reverse, and fracture shoulder systems but operates at vastly greater scale with broader joint reconstruction coverage.

TypeBroad incumbent
Description

One of the largest orthopedic device companies with a long-standing shoulder arthroplasty offering (including the Comprehensive and Sidus systems). Competes across the full shoulder procedure spectrum and has a global commercial footprint that Catalyst lacks.

3Johnson & Johnson (DePuy Synthes)
TypeBroad incumbent
Description

Through DePuy Synthes Mitek Sports Medicine, J&J offers the GLOBAL UNITE and other shoulder arthroplasty systems. A broad incumbent with the resources to develop stemless / patient-matched technologies that could compete with Catalyst's canal-sparing approach.

TypeBroad incumbent
Description

Orthopedic and sports medicine major with a focused shoulder portfolio including the AEQUALIS family of anatomic, reverse, and fracture shoulder systems. Closely comparable in shoulder-segment specialization though with broader portfolio diversification.

TypeBroad incumbent
Description

DJO Surgical (now part of Enovis) offers the AltiVate and EMPOWR shoulder arthroplasty systems. A relevant peer in shoulder reconstruction with overlapping anatomic and reverse product lines and similar mid-size orthopedic challenger dynamics.

6Exactech
TypeDirect peer
Description

Private shoulder and orthopedic implant company (acquired by TPG then reverted to private under PE ownership) offering the Equinoxe platform — one of the fastest-growing shoulder systems in the US and the closest direct peer to Catalyst in terms of size, focus, and growth profile.

TypeBroad incumbent
Description

Privately held orthopedic and sports medicine leader with a growing shoulder arthroplasty portfolio (Univers Revers, Eclipse stemless). Comparable in being a private, innovation-focused orthopedic company with strong surgeon education and training capabilities.

8Tornier (now part of Stryker)
TypeBroad incumbent
Description

Legacy shoulder-focused orthopedic company acquired by Wright Medical and then Stryker; historically a direct peer in stemless and reverse shoulder, now part of the broader Stryker portfolio.

TypeEmerging player
Description

Belgian 3D-printing and patient-specific instrumentation provider with orthopedic planning software and PSI capabilities. Closely comparable to Catalyst's 3D-Side partnership for Archer PSI and operates as an enabling technology partner in shoulder and joint reconstruction.

TypeOthers
Description

Digital surgery and surgical navigation company with growing orthopedic software and patient-specific planning offerings. Adjacent peer where Catalyst's Archer 3D Targeting Software competes for surgeon mind-share in preoperative planning workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Catalyst OrthoScience

Shoulder Arthroplasty Medical Devicescatalystortho.com

Catalyst OrthoScience is a private US medical device company founded in 2014 that develops and commercializes canal-sparing shoulder arthroplasty implant systems, including anatomic, reverse, fracture, and stemmed platforms, serving orthopedic surgeons and hospitals/ASCs through a direct domestic sales model.

What Catalyst OrthoScience does

Catalyst OrthoScience is a private medical device company founded in 2014 and headquartered in Naples, Florida that develops and commercializes shoulder arthroplasty implant systems. The company positions itself as a pure-play shoulder specialist offering a four-system portfolio covering the full shoulder replacement procedure spectrum: the stem-free Catalyst CSR Total Shoulder System (anatomic), the Catalyst Reverse Shoulder System (R1), the Catalyst Fracture Shoulder System (proximal humeral fractures), and the Catalyst Stemmed Anatomic Shoulder System. Its core technical differentiators include canal-sparing (stem-free and short-stem) implant designs, a proprietary non-spherical ellipsoid humeral head intended to replicate native anatomy, a patented multiplanar osteotomy technique, and a Plunge Reamer with automatic depth stop. The company also markets the Archer 3D Targeting Software for preoperative planning and the FDA-cleared Archer Patient-Specific Instrumentation (PSI) developed with Belgian partner 3D-Side, and claims to be the first and only company offering a single-tray portfolio spanning anatomic, reverse, and fracture procedures.

The company generates revenue through hardware sales of its implant systems and associated instruments to hospitals and ambulatory surgery centers (ASCs), supplemented by medical education services delivered through its seven-location Surgeon-to-Surgeon S.I.T.E. training program, webinars, and recorded surgical procedures. Distribution is exclusively domestic (United States) through direct field sales targeting orthopedic surgeons specializing in shoulder procedures, with contract-negotiated (non-public) implant pricing. Primary customers are orthopedic surgeons and the healthcare facilities where they practice, with secondary end-beneficiaries being patients suffering from shoulder arthritis, trauma, or fracture conditions. Catalyst reports cumulative clinical experience exceeding 10,000 shoulder arthroplasty procedures as of September 2024, with published 5-8 year outcome data on 206 shoulders, and holds over 50 issued or pending patents including US Patent D1,048,403 for tuberosity retention rails.

The business is venture-backed, having raised approximately $70 million+ across multiple rounds from 2016 through 2025, with lead investors including RC Capital, Mutual Capital Partners, and River Cities Capital. The company maintains 11-50 employees, is led by CEO Carl O'Connell, and has professionalized its leadership since 2024 with new CCO, CMO, and senior board appointments (including industry veterans from Johnson & Johnson, Tornier, Stryker, and Wright Medical). Recent strategic activity includes FDA 510(k) clearances for the Archer PSI system (February 2026) and expanded Fracture Shoulder System indications (December 2025), positioning Catalyst for portfolio expansion within the shoulder arthroplasty specialty.

Catalyst OrthoScience firmographics

Firmographics
Name
Catalyst OrthoScience
Legal name
Catalyst OrthoScience Inc.
Website
https://catalystortho.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Catalyst OrthoScience is a private US medical device company founded in 2014 that develops and commercializes canal-sparing shoulder arthroplasty implant systems, including anatomic, reverse, fracture, and stemmed platforms, serving orthopedic surgeons and hospitals/ASCs through a direct domestic sales model.
Ownership category
akta.pro rank

Catalyst OrthoScience industry classification

Industry
Product category
Shoulder Arthroplasty Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Shoulder arthroplasty systems
  • Orthopedic shoulder implants
  • Canal-sparing technology
  • Reverse shoulder replacement
  • Preoperative surgical planning

Where Catalyst OrthoScience is headquartered

Location

Headquarters

HQ city
Naples
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Catalyst OrthoScience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales - Shoulder Implant Systems: Catalyst OrthoScience generates revenue through the sale of its proprietary shoulder arthroplasty implant systems, including the CSR Total Shoulder System, Reverse Shoulder System, Fracture Shoulder System, and Stemmed Anatomic Shoulder System. Products are sold to hospitals, ambulatory surgery centers (ASCs), and directly to orthopedic surgeons. The company also sells associated instruments, instrumentation sets, and accessory products such as the Tuberosity Repair Kit.
  2. Medical Education Services: The company provides medical education programs including the Surgeon-to-Surgeon S.I.T.E. program, virtual learning sessions, webinars, recorded surgical procedures, and journal reviews. These programs serve both as revenue-generating services and as GTM tools to drive product adoption.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Catalyst OrthoScience product offering

Product offering

Core offering

Catalyst OrthoScience designs, develops, and commercializes proprietary shoulder arthroplasty implant systems — including the stem-free CSR Total Shoulder System, Reverse Shoulder System, Fracture Shoulder System, and Stemmed Anatomic — for hospitals, ambulatory surgery centers, and orthopedic surgeons performing anatomic, reverse, and fracture shoulder replacement procedures. The portfolio is complemented by the Archer 3D Targeting Software for preoperative planning and the FDA-cleared Archer Patient-Specific Instrumentation (PSI) for surgical execution.

Product overview

Catalyst OrthoScience is a medical technology company specializing in shoulder arthroplasty, offering a portfolio of implant systems designed around four core principles: precision placement, anatomic design, bone preservation, and tissue sparing. The product portfolio centers on five main systems: (1) the Catalyst CSR Total Shoulder System - a stem-free anatomic system featuring an elliptical humeral head and multiplanar osteotomy; (2) the Catalyst Reverse Shoulder System - a single-tray reverse arthroplasty system with bone-sparing inlay stem design; (3) the Catalyst Fracture Shoulder System - specifically designed for proximal humeral fractures with tuberosity management features; (4) the Catalyst Stemmed Anatomic Shoulder System - the company's first stemmed system with convertible capability; and (5) the Archer digital health ecosystem - comprising 3D Targeting Software for preoperative planning and Patient-Specific Instrumentation (PSI) for precise intraoperative execution. The company positions itself as a 'pure play shoulder company' focused exclusively on advancing shoulder arthroplasty through surgeon-focused innovation and procedural efficiency, claiming to be the first and only company offering a single-tray portfolio for anatomic, reverse, and fracture procedures.

Differentiator

Problem solved

Functional benefit

Brands

  • Catalyst CSR Total Shoulder System: Anatomic shoulder system with elliptical humeral head design for more natural shoulder replacement.
  • Catalyst Reverse Shoulder System
  • Catalyst Fracture Shoulder System
  • Catalyst Stemmed Anatomic
  • Archer 3D Targeting Software

Products and services

  • Catalyst CSR Total Shoulder System A stem-free anatomic total shoulder arthroplasty system featuring an elliptical (non-spherical) humeral head designed to replicate native anatomy, with patented multiplanar osteotomy for bone preservation, the Plunge Reamer for automatic depth-controlled preparation, and tissue-sparing instrumentation enabling a subscapularis-sparing surgical approach; targeted at orthopedic surgeons performing anatomic shoulder replacement in hospitals and ambulatory surgery centers.
  • Catalyst Reverse Shoulder System (R1) A reverse shoulder arthroplasty system with a 139-degree metaphyseal-fitting bone-sparing inlay humeral stem, glenosphere options of 32, 36, and 40mm with up to 10mm lateralization, poly inserts with 0–16mm offset, and single-tray instrumentation that reduces surgical steps by up to 46% compared with competitive reverse systems; intended for orthopedic surgeons performing reverse shoulder replacement in hospitals and ASCs.
  • Catalyst Fracture Shoulder System A fracture-specific reverse shoulder arthroplasty system for proximal humeral fractures featuring a tuberosity-specific fossa, patented Tuberosity Retention Rails (US Patent D1,048,403), 135-degree anatomic neck-shaft angle, and press-fit diaphyseal fixation, with FDA 510(k) clearance for expanded anatomic indications; intended for orthopedic surgeons managing proximal humeral fractures in hospitals and ASCs.
  • Catalyst Stemmed Anatomic Shoulder System The first stemmed total shoulder arthroplasty system with an elliptical humeral head, allowing conversion between anatomic hemi-arthroplasty and reverse humerus without stem removal, and compatible with the 3-peg glenoid and Catalyst humeral stems in 36mm and 41mm diameters with short and long options; targeted at orthopedic surgeons needing a convertible stemmed option.
  • Archer 3D Targeting Software Preoperative shoulder planning software encompassing both anatomic and reverse planning capabilities; creates interactive 3D renderings from patient imaging and delivers personalized surgical plans with individualized implant sizing and placement determination for orthopedic surgeons planning shoulder arthroplasty.
  • Archer Patient-Specific Instrumentation (PSI) FDA 510(k)-cleared patient-specific instrumentation providing a full suite of humeral and glenoid guides tailored to individual patient anatomy, developed in partnership with Belgian medtech company 3D-Side, enabling orthopedic surgeons to translate 3D preoperative plans into the OR with greater precision and reduced procedural steps; intended for shoulder arthroplasty cases where preoperative Catalyst Archer plans are used.

Quantifiable outcome

  • Preserves up to 50% more healthy bone compared to other stemless designs through patented multiplanar osteotomy
  • +6 more outcomes

Companies that use Catalyst OrthoScience

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Catalyst OrthoScience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Catalyst OrthoScience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 3D-SidecoreTechnology or Integration · 25 February 2026Belgian medtech company 3D-Side partnered with Catalyst to develop the Archer Patient-Specific Instrumentation (PSI) system. The PSI enables orthopedic surgeons to execute 3D preoperative plans with greater precision and reduced procedural steps. FDA 510(k) clearance received February 2026.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Catalyst OrthoScience competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Global orthopedic giant with a comprehensive shoulder arthroplasty portfolio (anchored by the Wright Medical shoulder franchise). Directly competes with Catalyst across anatomic, reverse, and fracture shoulder systems but operates at vastly greater scale with broader joint reconstruction coverage.
  • Zimmer Biomet: One of the largest orthopedic device companies with a long-standing shoulder arthroplasty offering (including the Comprehensive and Sidus systems). Competes across the full shoulder procedure spectrum and has a global commercial footprint that Catalyst lacks.
  • Johnson & Johnson (DePuy Synthes): Through DePuy Synthes Mitek Sports Medicine, J&J offers the GLOBAL UNITE and other shoulder arthroplasty systems. A broad incumbent with the resources to develop stemless / patient-matched technologies that could compete with Catalyst's canal-sparing approach.
  • Smith+Nephew: Orthopedic and sports medicine major with a focused shoulder portfolio including the AEQUALIS family of anatomic, reverse, and fracture shoulder systems. Closely comparable in shoulder-segment specialization though with broader portfolio diversification.
  • Enovis (DJO Surgical): DJO Surgical (now part of Enovis) offers the AltiVate and EMPOWR shoulder arthroplasty systems. A relevant peer in shoulder reconstruction with overlapping anatomic and reverse product lines and similar mid-size orthopedic challenger dynamics.
  • Arthrex: Privately held orthopedic and sports medicine leader with a growing shoulder arthroplasty portfolio (Univers Revers, Eclipse stemless). Comparable in being a private, innovation-focused orthopedic company with strong surgeon education and training capabilities.
  • Tornier (now part of Stryker): Legacy shoulder-focused orthopedic company acquired by Wright Medical and then Stryker; historically a direct peer in stemless and reverse shoulder, now part of the broader Stryker portfolio.

Direct peers

  • Exactech: Private shoulder and orthopedic implant company (acquired by TPG then reverted to private under PE ownership) offering the Equinoxe platform — one of the fastest-growing shoulder systems in the US and the closest direct peer to Catalyst in terms of size, focus, and growth profile.

Emerging players

  • Materialise: Belgian 3D-printing and patient-specific instrumentation provider with orthopedic planning software and PSI capabilities. Closely comparable to Catalyst's 3D-Side partnership for Archer PSI and operates as an enabling technology partner in shoulder and joint reconstruction.

Others

  • Brainlab: Digital surgery and surgical navigation company with growing orthopedic software and patient-specific planning offerings. Adjacent peer where Catalyst's Archer 3D Targeting Software competes for surgeon mind-share in preoperative planning workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Catalyst OrthoScience social profiles

Digital presence

Catalyst OrthoScience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Catalyst OrthoScience leadership team

Management profile

Number of profiles

Profiles8 records

Catalyst OrthoScience funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Catalyst OrthoScience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Catalyst OrthoScience

What does Catalyst OrthoScience do?

Catalyst OrthoScience designs, develops, and commercializes proprietary shoulder arthroplasty implant systems — including the stem-free CSR Total Shoulder System, Reverse Shoulder System, Fracture Shoulder System, and Stemmed Anatomic — for hospitals, ambulatory surgery centers, and orthopedic surgeons performing anatomic, reverse, and fracture shoulder replacement procedures. The portfolio is complemented by the Archer 3D Targeting Software for preoperative planning and the FDA-cleared Archer Patient-Specific Instrumentation (PSI) for surgical execution.

Is Catalyst OrthoScience a public or private company?

Catalyst OrthoScience is a private company. It is classified as venture growth investor backed and is currently operating.

When was Catalyst OrthoScience founded?

Catalyst OrthoScience was founded in 2014. It employs 51 to 100 people.

Where is Catalyst OrthoScience based?

Catalyst OrthoScience is headquartered in Naples, United States, in the North America region.

How does Catalyst OrthoScience make money?

Two revenue lines are on record. Medical Device Sales - Shoulder Implant Systems are the primary driver. The others are medical Education Services.

Who are Catalyst OrthoScience's main competitors?

Broad incumbents on record are Stryker, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Smith+Nephew, Enovis (DJO Surgical), Arthrex and Tornier (now part of Stryker). Exactech is listed as a direct peer. Materialise is listed as an emerging player. Brainlab is listed as an others.

Does Catalyst OrthoScience have an API?

No public API is recorded for Catalyst OrthoScience.

What industry is Catalyst OrthoScience in?

Catalyst OrthoScience's product category is Shoulder Arthroplasty Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerRedefine raises USD 10M in pre-seed financing roundRedefine Surgery closed an oversubscribed pre-seed round, raising $10 million total, with Catalyst OrthoScience joining as Founding Partner. The funds will support development of its surgical intelligence platform, targeting shoulder replacement procedures. The company will showcase its technology at ICSES in Vancouver.Financial PostRedefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience PartnershipRedefine Surgery closed an oversubscribed pre-seed round, raising $10 million total, and announced Catalyst OrthoScience as a Founding Partner. The partnership aims to develop an integrated surgical intelligence ecosystem for shoulder replacement procedures. The company will showcase its technology at ICSES in Vancouver.FinancialContent Business PageRedefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience PartnershipRedefine Surgery closed an oversubscribed pre-seed round raising $10 million, with Catalyst OrthoScience joining as Founding Partner. The partnership aims to develop surgical intelligence for shoulder arthroplasty, with the platform under development and commercialization subject to regulatory clearance.YahooRedefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience PartnershipRedefine Surgery closed an oversubscribed pre-seed round raising $10 million, with Catalyst OrthoScience joining as Founding Partner. The partnership aims to develop surgical intelligence for shoulder arthroplasty, with the platform under development and commercialization subject to regulatory clearance.RedefinesurgeryRedefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience Partnership — redefine surgeryRedefine Surgery closed an oversubscribed pre-seed round raising $10 million, with Catalyst OrthoScience joining as Founding Partner. The partnership aims to develop surgical intelligence for shoulder arthroplasty, with the platform under development and commercialization subject to regulatory clearance.BioSpaceCatalyst OrthoScience Joins Redefine Surgery as Founding Partner in ShoulderCatalyst OrthoScience became founding partner with Redefine Surgery for shoulder replacement, aiming to create a surgical intelligence ecosystem. The partnership targets up to four times more efficiency in procedure time and ten times less technology cost. The companies plan to develop an integrated ecosystem spanning preoperative planning through procedural analysis.MorningstarRedefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience PartnershipRedefine Surgery closed an oversubscribed pre-seed round raising $10 million, with Catalyst OrthoScience joining as Founding Partner. The partnership aims to develop surgical intelligence for shoulder arthroplasty, with the platform under development and commercialization subject to regulatory clearance.Business Wire BlogCatalyst OrthoScience Joins Redefine Surgery as Founding Partner in ShoulderCatalyst OrthoScience joined Redefine Surgery as founding partner in shoulder, aiming to create a surgical intelligence ecosystem. The partnership targets up to four times more efficiency in procedure time and ten times less technology cost. The companies plan to develop an integrated ecosystem spanning preoperative planning through procedural analysis.Business Wire BlogCatalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder InnovationsCatalyst OrthoScience announced a settlement agreement with Shoulder Innovations to resolve all pending patent litigation between the two companies. The terms of the settlement are confidential. Catalyst's CEO said the agreement allows both companies to move beyond the dispute.OrthotwCatalyst OrthoScience Appoints Gordon Van Ummersen to Board of DirectorsCatalyst OrthoScience Inc. has appointed Gordon Van Ummersen to its board of directors, effective immediately. The company cites Van Ummersen's extensive executive leadership experience in healthcare and medical technology as valuable for advancing its next phase of growth and strategic objectives. This appointment is intended to enhance board depth as the shoulder-focused medtech company continues to expand its market presence.